Active Pharmaceutical Ingredients(API’s)
Chemeca Drugs Private Limited, Visakhapatnam
| SNo | Product | Pharmacopeia | CAS No | Therapeutic Area | Regulatory Status | ||||
|---|---|---|---|---|---|---|---|---|---|
| Commercial Scale Products | USP | EP/CEP | NMPA | HEALTH CANANDA | Korea | ||||
| 1 | Sertraline HCl | IP/USP/Ph.Eur | 79559-97-0 | Antidepressant | Yes-033535 | EDMF | Ready to submit | ||
| 2 | Diltiazem HCl | IP/USP/Ph. Eur/ JP/BP | 33286-22-5 | Antianginal, Antihypertensive | Yes-034220 | CEP submitted under review | Submitted under review | ||
| 3 | Carisoprodol | USP/Ph.Eur/IP | 78-44-4 | Muscle Relaxant | Yes-03149 | N/A | |||
| 4 | Bupropion HCl | USP | 31677-93-7 | Antidepressant | Yes-035418 | EDMF | e-282490 | ||
| 5 | Clopidogrel bisulfate | USP | 120202-66-6 | Antiplatelet agents, | Yes-033710 | CEP-2021-433-Rev-00 | |||
| Neurotransmitter Agents, | |||||||||
| Hematologic Agents | |||||||||
| 6 | Fexofenadine HCl | USP/Ph.Eur | 153439-40-8 | Antihistamine | Yes-036554 | EDMF | Submitted under review | Submitted | |
| 7 | Pirfenidone | IP/USP/Ph.Eur | 53179-13-8 | Anti – Inflammatory Agent | N/A | EDMF | |||
| 8 | Quetiapine Fumarate | IP/USP/Ph.Eur | 111974-72-2 | Antipsychotic Agent | Yes-037315 | ||||
| 9 | Celecoxib | USP/Ph.Eur | 169590-42-5 | Anti-Inflammatory | Yes-037530 | To be submitted | |||
| 10 | Hydralazine Hydrochloride | USP | 304-20-1 | Antihypertensive | Yes-038732 | ||||
| 11 | Bupropion HBR | USP | 905818-69-1 | Antidepressant | Yet to be filed,Validation under progress | ||||
Development Products
| SNo | Product | Pharmacopeia | CAS No | Therapeutic Area | Regulatory Status |
|---|---|---|---|---|---|
| 1 | Bupropion Hydrobromide | IH | 905818-69-1 | Antidepressant | Under validation |
| 2 | Tolvaptan | IH | 150683-30-0 | Aquaretic | Under-development |
| 3 | Sodium pico sulfate | USP/EP | 1307301-38-7 | Constipation | Under-development |
| 4 | Rifaximin | IH/EP | 80621-81-4 | Antibacterial | Under-development |
| 5 | Empagliflozin | IH | 864070-44-0 | Antidiabetic | Under-development |
| 6 | Dapagliflozin | IH | 461432-26-8 | Antidiabetic | Under-development |
| 7 | Finerenone | IH | 1050477-31-0 | Non-steroidal mineralocorticoid receptor antagonist | Under-development |
SNo | Product | Pharmacopeia | CAS No | Therapeutic Area | Regulatory Status | |
|---|---|---|---|---|---|---|
Commercial Scale Products | USDMF | CEP/EDMF | ||||
1 | Sertraline HCl | IP/USP/Ph.Eur | 79559-97-0 | Antidepressant | Yes-033535 | EDMF |
2 | Diltiazem HCl | IP/USP/Ph. Eur/ JP/BP | 33286-22-5 | Antianginal, Antihypertensive | Yes-034220 | EDMF |
3 | Carisoprodol | USP/Ph.Eur/IP | 78-44-4 | Muscle Relaxant | Yes-03149 | N/A |
4 | Bupropion HCl | USP | 31677-93-7 | Antidepressant | Yes-035418 | EDMF |
5 | Clopidogrel bisulfate | USP | 120202-66-6 | Antiplatelet agents, Neurotransmitter Agents, Hematologic Agents | Yes-033710 | CEP* |
6 | Fexofenadine HCl | USP/Ph.Eur | 153439-40-8 | Antihistamine | Yes-036554 | EDMF |
7 | Pirfenidone | IP/USP/Ph.Eur | 53179-13-8 | Anti – Inflammatory Agent | N/A | EDMF |
8 | Quetiapine Fumarate | IP/USP/Ph.Eur | 111974-72-2 | Antipsychotic Agent | Yes-037315 | |
9 | Celecoxib | USP/Ph.Eur | 169590-42-5 | Anti-Inflammatory | Yes-037530 | |
10 | Hydralazine Hydrochloride | USP | 304-20-1 | Antihypertensive | Yet to be filed, Validation completed | |
Development Products | ||||||
11 | Tapentadol | IP/IHS | 175591-09-0 | Opioid Analgesic | V | |
12 | Rivaroxaban | IH | 366789-02-8 | Anticoagulant | V | |
N/A: Not Applicable; EDMF- EDMF filed/Ready for filing ; *- Application filed and Under review; V- Product validation under progress | ||||||
SNo | Product | Pharmacopeia | CAS No | Therapeutic Area | Regulatory Status | |
|---|---|---|---|---|---|---|
Commercial Scale Products | USDMF | CEP/EDMF | ||||
1 | Sertraline HCl | IP/USP/Ph.Eur | 79559-97-0 | Antidepressant | Yes-033535 | EDMF |
2 | Diltiazem HCl | IP/USP/Ph. Eur/ JP/BP | 33286-22-5 | Antianginal, Antihypertensive | Yes-034220 | EDMF |
3 | Carisoprodol | USP/Ph.Eur/IP | 78-44-4 | Muscle Relaxant | Yes-03149 | N/A |
4 | Bupropion HCl | USP | 31677-93-7 | Antidepressant | Yes-035418 | EDMF |
5 | Clopidogrel bisulfate | USP | 120202-66-6 | Antiplatelet agents, Neurotransmitter Agents, Hematologic Agents | Yes-033710 | CEP* |
6 | Fexofenadine HCl | USP/Ph.Eur | 153439-40-8 | Antihistamine | Yes-036554 | EDMF |
7 | Pirfenidone | IP/USP/Ph.Eur | 53179-13-8 | Anti – Inflammatory Agent | N/A | EDMF |
8 | Quetiapine Fumarate | IP/USP/Ph.Eur | 111974-72-2 | Antipsychotic Agent | Product validation in Plant over, DMF under preparation | |
9 | Celecoxib | USP/Ph.Eur | 169590-42-5 | Anti-Inflammatory | Product validation in Plant over, DMF under preparation | |
Development Products | ||||||
10 | Tapentadol | IP/IHS | 175591-09-0 | Opioid Analgesic | V | |
11 | Rivaroxaban | IH | 366789-02-8 | Anticoagulant | V | |
12 | Hydralazine HCl | 304-20-1 | Antihypertensive | V | ||
N/A: Not Applicable; EDMF- EDMF filed/Ready for filing ; *- Application filed and Under review; V- Product validation under progress | ||||||
Product | CAS No | Pharmacopeia | Therapeutic Area | Accreditations |
|---|---|---|---|---|
Sertraline HCL | 79559-97-0 | IP/USP/Ph.Eur | Antidepressant | USDMF No. (033535) |
Diltiazem HCL | 33286-22-5 | IP/USP/Ph. Eur/ JP/BP | Antianginal, antiarrhythmic (class IV), antihypertensive | USDMF No. (034220) |
Carisoprodol | 78-44-4 | USP/Ph.Eur/IP | muscle relaxant | US DMF No. (035149) |
Bupropion Hcl | 31677-93-7 | USP | antidepressant | USDMF No. (035418) |
Clopidogrel bisulfate | 120202-66-6 | USP | Antiplatelet agents, Neurotransmitter Agents, Hematologic Agents | USDMF No. (033710) |
Fexofenadine Hydrochloride | 153439-40-8 | USP/Ph.Eur | antihistamine | USDMF No. (036554) |
Pirfenidone | 53179-13-8 | IP/USP/Ph.Eur | Anti – inflammatory agent, Idiopathic pulmonary fibrosis | Under US DMF filling /Regular |
Zidovudine | 30516-87-1 | IP/USP/Ph.Eur | ARV | Companion |
Biperiden Hydrochloride | 1235-82-1 | USP,EP | Anti-Dyskinesia Agents, Central Nervous System Agents, Anti-Parkinson Drugs | Companion |
Pantoprazole Sodium | 138786-67-1 | IP/USP/Ph.Eur | Healing and Symptomatic relief of erosive esophagitis. | Regular |
Rabeprazole Sodium | 117976-90-6 | IP/Ph. Eur/ JP/BP | Short-term treatment of erosive or ulcerative gastroesophageal reflux disease (GERD) | Regular |
Aripiprazole | 129722-12-9 | IP/Ph. Eur/ JP | Antipsychotic Agent | Not available |
Dexalansoprazole | 138530-94-6 | IP/HIS | Gastroesophageal Reflux Disease | Not available |
Duloxetine Hydrochloride | 136434-34-9 | Ph. Eur/USP | Antidepressant Agent and Anxiolytic | Companion |
Quetiapine Fumarate | 111974-72-2 | IP/USP/Ph.Eur | Antipsychotic Agent | Companion |
Levetiracetam | 102767-28-2 | USP | Anticonvulsant Agent | Not available |
Domperidone | 57808-66-9 | IP/Ph.Eur | Antiemetic, gastroprokinetic agent and galactagogue | Not available |
Esomeprazole Magnesium Trihydrate | 217087-09-7 | IP/USP/Ph.Eur | Inhibitor of gastric acid secretion | Companion |
Tapentadol | 175591-09-0 | IP/IHS | Opioid Analgesic | Regular |
Moxifloxacin Hydrochloride | 354812-41-2 | USP/Ph.Eur/IP | antibiotic | Companion |
Itraconazole | 84625-61-6 | Ph.Eur/USP/J | antifungal | Companion |
Atorvastatin Calcium | 134523-00-5 | USP | cardiovascular | Companion |
Atorvastatin Calcium Trihydrate | 344423-98-9. | Ph.Eur | cardiovascular | Companion |
Olmesartan Medoxomil | 144689-63-4 | USP/Ph.Eur | Anty hypertension | Companion |
Sitagliptin Phosphate Mono Hydrate | 654671-77-9 | IP/HIS | Anti diabatic | Companion |
Lisinopril | 83915-83-7 | USP | Blood Pressure. | R&D |
Nabumetone | 42924-53-8 | USP/Ph.Eur | NSAIDs. | R&D |
Celecoxib | 169590-42-5 | USP/Ph.Eur | anti-inflammatory | R&D |
Apixaban | 503612-47-3 | IH | anticoagulant | Samples |
Rivaroxaban | 366789-02-8 | IH | anticoagulant | Samples |
| Active Pharmaceutical Ingredients |
|---|
| Sertraline Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Pirfenidone |
| Active Pharmaceutical Ingredients |
|---|
| Diltiazem Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Bupropion Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Carisoprodol |
| Active Pharmaceutical Ingredients |
|---|
| Clopidogrel Bisulfate |
| Active Pharmaceutical Ingredients |
|---|
| Zidovudine |
| Active Pharmaceutical Ingredients |
|---|
| Fexofenadine Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Tapentadol Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Quetiapine Fumarate |
| Active Pharmaceutical Ingredients |
|---|
| Sertraline Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Diltiazem HCl |
| Active Pharmaceutical Ingredients |
|---|
| Carisoprodol |
| Active Pharmaceutical Ingredients |
|---|
| Bupropion HCl |
| Active Pharmaceutical Ingredients |
|---|
| Clopidogrel bisulfate |
| Active Pharmaceutical Ingredients |
|---|
| Fexofenadine HCl |
| Active Pharmaceutical Ingredients |
|---|
| Pirfenidone |
| Active Pharmaceutical Ingredients |
|---|
| Quetiapine Fumarate |
| Active Pharmaceutical Ingredients |
|---|
| Celecoxib |
| Active Pharmaceutical Ingredients |
|---|
| Hydralazine Hydrochloride |
Development
| Active Pharmaceutical Ingredients |
|---|
| Tapentadol |
| Active Pharmaceutical Ingredients |
|---|
| Rivaroxaban |
| Active Pharmaceutical Ingredients |
|---|
| Sertraline Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Pirfenidone |
| Active Pharmaceutical Ingredients |
|---|
| Diltiazem Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Bupropion Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Carisoprodol |
| Active Pharmaceutical Ingredients |
|---|
| Clopidogrel Bisulfate |
| Active Pharmaceutical Ingredients |
|---|
| Zidovudine |
| Active Pharmaceutical Ingredients |
|---|
| Fexofenadine Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Tapentadol Hydrochloride |
| Active Pharmaceutical Ingredients |
|---|
| Quetiapine Fumarate |
S.No. | Active Pharmaceutical Ingredients |
|---|---|
1 | Sertraline Hydrochloride |
2 | Pirfenidone |
3 | Diltiazem Hydrochloride |
4 | Bupropion Hydrochloride |
5 | Carisoprodol |
6 | Clopidogrel Bisulfate |
7 | Zidovudine |
8 | Fexofenadine Hydrochloride |
9 | Tapentadol Hydrochloride |
10 | Quetiapine Fumarate |
Chemeca Drugs Private Limited is a manufacturer of APIs and drug intermediates. Our manufacturing facility is located in JN Pharmacity, Visakhapatnam. The company was established in 2008.
Chemeca has become synonymous for its quality, commitment & transparency, making it a dependable & reliable partner to industry majors like DRL, Lupin, Sun Pharma, and Mylan, by entering into long term strategic relationships for new products.
With an expanding customer base and increasing demand for more products, our focus has grown to both drug intermediates and APIs. Our plant was designed to meet cGMP and WHO GMP requirements, and is in conformity with US FDA guidelines.